Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03704584 · ClinicalTrials.gov registry record · Phase 4
Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT03704584: Clinical Trial Phase 4 study, sponsored by Emory University.
NCT03704584 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 62 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03704584, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
The clinical trial is a randomized control trial to compare the efficacy of a combined lidocaine and corticosteroid (CS) injection versus a corticosteroid injection (CS) alone on pain, range of motion, and patient reported outcomes for the treatment of common upper extremity tendinopathies and nerve entrapments that are often treated with a combination of these injectates.
Primary Outcome
Pain will be assessed with a 10-point scale (0: no pain, 10: highest amount of pain) of anticipated pain and anxiety before injection and a 10-point pain scale of the pain of the needle, medication, overall pain and anxiety after the injection was administered to the participants.
Interventions
- DRUG Treatment Group: Corticosteroid injection
- DRUG Control Group (corticosteroid alone)
- DRUG Treatment Group: Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-05-14 |
| Est. Completion | 2020-01-14 |
| Phase | Phase 4 |
Why NCT03704584 stopped before completion
NCT03704584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which Treatment Group: Corticosteroid injection is the first listed.
NCT03704584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03704584 about?
NCT03704584 is a clinical study titled "Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone". The clinical trial is a randomized control trial to compare the efficacy of a combined lidocaine and corticosteroid (CS) injection versus a corticosteroid injection (CS) alone on pain, range of motion, and patient reported outcomes for the treatment of common upper extremity tendinopathies and nerve...
What is the current status of trial NCT03704584?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2019-05-14. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT03704584?
The interventions under investigation include: Treatment Group: Corticosteroid injection (DRUG), Control Group (corticosteroid alone) (DRUG), Treatment Group: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT03704584?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03704584's enrollment target sits among peer trials
62 1110th of 2000 higher than 882 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI